Wednesday, April 1, 2026
Study compares two surgical techniques for heart valve repair in rheumatic heart disease
Photo by Dan Meyers / Unsplash

Study compares two surgical techniques for heart valve repair in rheumatic heart disease

Plain Language Summary
What this means for you:
In a retrospective study, a tissue-based valve repair was linked to less long-term leakage, but more research is needed.

Researchers looked back at medical records to compare two surgical methods for fixing a leaky tricuspid heart valve in patients with rheumatic heart disease. The study involved 251 patients who had valve repair surgery. One group had surgery using a ring made from the patient's own pericardial tissue (P-TVP), while the other group had surgery using a manufactured prosthetic ring (A-TVP).

The main finding was that patients who received the repair using their own tissue had significantly lower rates of the valve leaking again (recurrence of moderate tricuspid regurgitation) at both 4 years and 8 years after surgery. Early results after surgery were similar between the two groups.

It is important to be careful with these results. This was a retrospective study, meaning researchers analyzed past patient data rather than assigning treatments randomly. Some follow-up information was also missing, which required statistical estimation. Therefore, the study shows a link between the tissue-based technique and better long-term results, but it does not prove the technique caused the better outcome. The findings apply specifically to patients with rheumatic heart disease and may not apply to others. Readers should see this as promising information that needs confirmation from more rigorous, prospective studies.

What this means for you:
In a retrospective study, a tissue-based valve repair was linked to less long-term leakage, but more research is needed.
Read the Full Clinical Summary →
View Original Abstract ↓
BackgroundTo compare the long-term efficacy of autologous pericardial soft-ring annuloplasty (P-TVP) versus prosthetic ring annuloplasty (A-TVP) for functional tricuspid regurgitation (FTR) secondary to rheumatic heart disease (RHD).MethodsA total of 251 consecutive RHD patients undergoing tricuspid annuloplasty from December 2013 to December 2023 were retrospectively analyzed. Among them, 139 underwent P-TVP and 112 received A-TVP. Propensity score matching (1:1) yielded 64 comparable pairs. Follow-up at 6,24,48 and 96 months assessed TR recurrence and right-heart remodeling. Multiple imputation was applied for partially missing follow-up data.ResultsEarly outcomes at 6 and 24 months were similar between groups. However, recurrence of moderate TR was significantly lower in the P-TVP group at 48 and 96 months (both P